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CAF strategies involved in cancer 
metastasis
Cancer associated fibroblasts as a potent cause for cancer metastasis
The beginning of a tumor consists in an in situ cell growing due to genetic alterations. The studies in recent years
showed an increasing importance of tumor stroma in cancer development, by providing the favorable
microenvironment to the tumor progression (“seed and soil” hypothesis). The most important cell type in tumor stroma
are the cancer associated fibroblasts (CAFs), which is in charge of a wide range of functions promoting cancer
development.
CAFs are involved in metastasis through mechanisms by exerting motility signaling in cancer cells or themselves.
Moreover, they are important crosstalk with many stromal components. The aim of this review is to analyze different
metastasis-promoting mechanisms of CAFs to assess the possibility of it’s targeting to reduce patient death.
Introduction
REVIEW
Motility stimulated by CAF-secreted paracrine factors
CAFs stimulate cancer cell’s motility.
1. CCL7 is recognized by adjacent
cancer cell via CCR1 or CCR3, in
order to induce cell motility ruffling,
as shown in fluorescent CCL7-
treated cell cocultures in
comparison to no treated ones. The
crosstalk between cancer cell and
CAF is via IL-1α secretion.
2. CAF-secreted FGF1 induces Ras-
MAPK-ERK1/2 signal downstream,
resulting in the adhesion contacts
disruption to facilitate cell migration.
3. Gal-1 affects to the integrin-β1
overexpression in order to improve
cell adhesion with glycolated ECM
or cell surface components.
Fig.1 Effects of different paracrine factors
Adapted from Jung et al., 2010
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Exosome-mediated cell motility
Exosomes are multivesicular
bodies secreted by CAFs, which
have been proved to participate
in many cancer-promoting
effects, due to their content
diversity.
CAF-secreted Cd-81 exosomes are
able to induce cancer cell
secreted Wnt11 association and its
maturation. The interaction of
Wnt11with Fzd6 affects the
subsequent PCP complexes and
disposes them in an asymmetrical
way in the leading cell protrusions.
As shown in cancer cell cocultures,
the exosome treated cells
presented protrusion formation
and Fzd6 localization to the
leading edge, favoring cell
migration.
Fig.2 Exosome migration promoting activity.
Adapted from Luga et al., 2012
Rho-dependent actin cytoskeleton contractility of CAFs
CAFs are also involved in ECM remodeling
through cytokine signaling (specifically IL-6),
which signals through GP130-IL6ST. The final
Rho-ROCK pathway gives place to
actomyosin contractility through MLC2
phosphorylation.
Cav-1 is separated from the cavin complex
by the stromal mechanical stress, which
favors the recruitment of p190RHOGap
disabling its inhibition on Rho.
Rho and ROCK activation generates actomyosin contractility in both stromal and cancer
cells, which enhances cytoskeleton-ECM communication through membrane integrins. At
all, Rho pathway generates contractile force in stromal fibroblasts to remodel the extracellular
matrix and create tracks for collective migration of carcinoma cells
Fig.4 Cytokine signaling to contractility
Based on Sanz-Moreno et al., 2011             
Fig.4 Cav-1 signaling to contractility
Adapted from Parton & del Pozo, 2013
Conclusions 
• CAFs are involved in many metastasis-promoting functions via different mechanisms. It’s high diversity of effects shows the need of further investigation
and more molecular mechanisms exploring, such as the new insights in their metastatic niche establishment.
• CAFs act by regulating motility of adjacent cancer cells, through secretion of paracrine and autocrine factors, inducing motility and more contacts
formation.
• They exert biomechanical effects on the ECM by inducing their own cytoskeleton changes  leading paths for cancer cell group migration
• Important CAF crosstalk with the microenvironment
Future perspectives
• Inhibition of CAFs also accelerates cancer progression  precaution in anti-CAFs therapies
• Specific CAF pathways targeting can be effective, but complicated due to multiple interactions
• Future treatment can focus in reverting to normal phenotype  restoring to normal stroma
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ECM collagen fiber alignment and modulation
The ECM provides biomechanical and
biochemical signals. The disruption of
matrix-cellular homeostasis could
enhance cancer progression and
metastasis. CAF can exert ECM
remodeling by ECM structure and
stiffness modification through
collagen (main ECM component)
overproduction and crosslinking to
elastin.
The different states of fiber
arrangement correspond to different
tissue alteration.
The higher ECM stiffness affects the
mechanosensing properties and
favors cancer cell orientated
migration (metastasis), by using the
collagen fibers as trails (Rho-ROCK
signaling).
CAFs also secrete MMPs, which degrade a variety of structural ECM components: collagens,
fibronectin, laminin, etc. CAF-secreted MMP 2 and MMP 9 are associated with basement
membrane collagen type IV degradation; while MMP 2 is also are involved in collagen
overexpression as same as MMP 3.
Fig.3 ECM fiber alignment in cáncer
Adapted from Malik, Lelkes, & Cukierman, 2015
• CCL7: cemokine ligand 7
• CCR: chemokine receptor
• IL-1a: interleukin 1a
• FGF1: fibroblast growth factor 1
• MAPK-ERK: mitogen activated
protein kinase-extracellular signal-
regulated kinase
• Gal-1: galectin 1
• Fzd6: frizzled 6
• ECM: extracellular matrix
• MMPs: matrix metalloproteinase
• IL-6: interleukin 6
• MLC: myosin light chain
• Cav1: caveolin-1
• LOX: lysyl oxidase
